Nevro - NVRO Stock Forecast, Price & News

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nevro in the last twelve months. There are currently 3 sell ratings, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NVRO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVRO, but not buy additional shares or sell existing shares.
View NVRO analyst ratings or view top-rated stocks.

14 analysts have issued 1-year target prices for Nevro's stock. Their NVRO share price forecasts range from $31.00 to $97.00. On average, they expect the company's share price to reach $64.50 in the next twelve months. This suggests a possible upside of 54.2% from the stock's current price.
View analysts price targets for NVRO or view top-rated stocks among Wall Street analysts.

Nevro's stock was trading at $81.07 at the beginning of 2022. Since then, NVRO shares have decreased by 48.4% and is now trading at $41.84.
View the best growth stocks for 2022 here.

Nevro saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 3,330,000 shares, an increase of 58.6% from the October 15th total of 2,100,000 shares. Based on an average daily trading volume, of 629,700 shares, the short-interest ratio is presently 5.3 days. Currently, 10.0% of the company's shares are sold short.
View Nevro's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our NVRO earnings forecast.

Nevro Corp. (NYSE:NVRO) released its quarterly earnings results on Wednesday, November, 2nd. The medical equipment provider reported ($0.62) EPS for the quarter, beating the consensus estimate of ($0.71) by $0.09. The medical equipment provider earned $100.47 million during the quarter, compared to the consensus estimate of $99.08 million. Nevro had a negative net margin of 2.01% and a negative trailing twelve-month return on equity of 40.89%.

Nevro issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $403.00 million-$407.00 million, compared to the consensus revenue estimate of $405.06 million.

9 employees have rated Nevro Chief Executive Officer D. Keith Grossman on Glassdoor.com. D. Keith Grossman has an approval rating of 68% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nevro investors own include AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), General Electric (GE), Micron Technology (MU), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Adobe (ADBE) and Intuitive Surgical (ISRG).

Nevro trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVRO."

Nevro's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (13.75%), Vanguard Group Inc. (10.22%), Fred Alger Management LLC (2.63%), Federated Hermes Inc. (2.35%), State Street Corp (2.32%) and Brown Advisory Inc. (1.82%). Insiders that own company stock include Andrew H Galligan, D Keith Grossman, Elizabeth H Weatherman, Kashif Rashid, Kevin C Oboyle, Leslie Stretch, Michael F Demane, Michael F Demane, Niamh Louise Pellegrini and Shawn Mccormick.
View institutional ownership trends.

Shares of NVRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NVRO stock can currently be purchased for approximately $41.84.

Nevro (NYSE:NVRO) has a market capitalization of $1.48 billion and generates $386.90 million in revenue each year. The medical equipment provider earns $-131,360,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis.

The company employs 945 workers across the globe.

Nevro's mailing address is 1800 BRIDGE PARKWAY, REDWOOD CITY CA, 94065. The official website for the company is www.nevro.com. The medical equipment provider can be reached via phone at (650) 251-0005 or via email at ir@nevro.com.